Paper36725929
Structural basis for substrate selection by the SARS-CoV-2 replicase.
Malone BF and 18 others. Nature, 2023. Cited by 77 papers, by iCite.
Cite this record
ConductScience Library. Structural basis for substrate selection by the SARS-CoV-2 replicase. Papers, record 36725929. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36725929
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Coronavirus RNA-Dependent RNA Polymerase | Major topic |
| Cryoelectron Microscopy | Major topic |
| SARS-CoV-2 | Major topic |
| Humans | |
| Antiviral Agents | |
| COVID-19 | |
| Nucleosides | |
| RNA, Viral | |
| Substrate Specificity | |
| Guanosine Triphosphate | |
| RNA Caps | |
| Adenosine Monophosphate | |
| Alanine | |
| Adenosine Triphosphate |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P41 GM109824 | NIGMS NIH HHS | United States | P41GM109824 | PubMed and NIH | NIH RePORTER |
| R01 AI161278 | NIAID NIH HHS | United States | R01AI161278 | PubMed and NIH | NIH RePORTER |
| P41GM103310 | NIH | NIH RePORTER | |||
| P41GM103314 | NIH | NIH RePORTER | |||
| U24GM129539 | NIH | NIH RePORTER |
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34824452 | Structures and functions of coronavirus replication-transcription complexes and their relevance for SARS-CoV-2 drug design. | Nat Rev Mol Cell Biol | 2022 | https://conductscience.org/library/papers/34824452 | PubMed |
| 2 | 32445440 | Remdesivir for the Treatment of Covid-19 - Final Report. | N Engl J Med | 2020 | https://conductscience.org/library/papers/32445440 | PubMed |
| 3 | 33283177 | Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase. | iScience | 2020 | https://conductscience.org/library/papers/33283177 | PubMed |
| 4 | 32284326 | Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency. | J Biol Chem | 2020 | https://conductscience.org/library/papers/32284326 | PubMed |
| 5 | 33472860 | Coronavirus replication-transcription complex: Vital and selective NMPylation of a conserved site in nsp9 by the NiRAN-RdRp subunit. | Proc Natl Acad Sci U S A | 2021 | https://conductscience.org/library/papers/33472860 | PubMed |
| 6 | 35944563 | The mechanism of RNA capping by SARS-CoV-2. | Nature | 2022 | https://conductscience.org/library/papers/35944563 | PubMed |
| 7 | 34914868 | Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients. | N Engl J Med | 2022 | https://conductscience.org/library/papers/34914868 | PubMed |
| 8 | 12654997 | A structural and primary sequence comparison of the viral RNA-dependent RNA polymerases. | Nucleic Acids Res | 2003 | https://conductscience.org/library/papers/12654997 | PubMed |
| 9 | 34617885 | Inhibition of SARS-CoV-2 polymerase by nucleotide analogs from a single-molecule perspective. | Elife | 2021 | https://conductscience.org/library/papers/34617885 | PubMed |
| 10 | 10364165 | DNA polymerases: structural diversity and common mechanisms. | J Biol Chem | 1999 | https://conductscience.org/library/papers/10364165 | PubMed |
| 11 | 25678663 | Viral replication. Structural basis for RNA replication by the hepatitis C virus polymerase. | Science | 2015 | https://conductscience.org/library/papers/25678663 | PubMed |
| 12 | 27339134 | Structural basis of viral RNA-dependent RNA polymerase catalysis and translocation. | Proc Natl Acad Sci U S A | 2016 | https://conductscience.org/library/papers/27339134 | PubMed |
| 13 | 18184655 | Structural insights into mechanisms of catalysis and inhibition in Norwalk virus polymerase. | J Biol Chem | 2008 | https://conductscience.org/library/papers/18184655 | PubMed |
| 14 | 33357445 | Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma. | Cell | 2021 | https://conductscience.org/library/papers/33357445 | PubMed |
| 15 | 32438371 | Structure of replicating SARS-CoV-2 polymerase. | Nature | 2020 | https://conductscience.org/library/papers/32438371 | PubMed |
| 16 | 32526208 | Structural Basis for RNA Replication by the SARS-CoV-2 Polymerase. | Cell | 2020 | https://conductscience.org/library/papers/32526208 | PubMed |
| 17 | 35260847 | Ensemble cryo-EM reveals conformational states of the nsp13 helicase in the SARS-CoV-2 helicase replication-transcription complex. | Nat Struct Mol Biol | 2022 | https://conductscience.org/library/papers/35260847 | PubMed |
| 18 | 33526596 | Structure of the SARS-CoV-2 RNA-dependent RNA polymerase in the presence of favipiravir-RTP. | Proc Natl Acad Sci U S A | 2021 | https://conductscience.org/library/papers/33526596 | PubMed |
| 19 | 35110538 | A dual mechanism of action of AT-527 against SARS-CoV-2 polymerase. | Nat Commun | 2022 | https://conductscience.org/library/papers/35110538 | PubMed |
| 20 | 23954653 | One number does not fit all: mapping local variations in resolution in cryo-EM reconstructions. | J Struct Biol | 2013 | https://conductscience.org/library/papers/23954653 | PubMed |
Cited by48
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 77 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42948681 | Identification and characterization of a non-nucleotide RdRp allosteric inhibitor with pan-coronavirus protection. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/42948681 | PubMed |
| 42928375 | Molecular basis of DNA polymerase ζ's reverse transcriptase activity. | Nat Commun | 2026 | https://conductscience.org/library/papers/42928375 | PubMed |
| 42655159 | Structural and Mechanistic Perspectives on SARS-CoV-2 Nonstructural Protein 14-Mediated Cap Formation and Drug Discovery. | Microorganisms | 2026 | https://conductscience.org/library/papers/42655159 | PubMed |
| 42429789 | Virologic insights from the phase 3 REDPINE trial: remdesivir in renally impaired and immunocompromised patients with COVID-19. | Antimicrob Agents Chemother | 2026 | https://conductscience.org/library/papers/42429789 | PubMed |
| 42409264 | Substrate and target selectivity of 4'-fluoroadenosine against viral and host polymerases. | J Biol Chem | 2026 | https://conductscience.org/library/papers/42409264 | PubMed |
| 42357443 | Positive-Strand RNA Viral RdRps: From Structure Conservation and Activity Assay to Drug Development. | Molecules | 2026 | https://conductscience.org/library/papers/42357443 | PubMed |
| 42192108 | Discovering novel multi-target compounds against aspartyl viral polymerases via ligand-based pharmacophore and structure-based screening. | Sci Rep | 2026 | https://conductscience.org/library/papers/42192108 | PubMed |
| 42089609 | Loss of nsp14-exonuclease activity impairs the replication, proofreading, fitness, and pathogenesis of SARS-CoV-2. | mBio | 2026 | https://conductscience.org/library/papers/42089609 | PubMed |
| 41889778 | Microsecond Dynamics of the Pyrophosphate Ion Release in SARS-CoV‑2 RNA Polymerase. | JACS Au | 2026 | https://conductscience.org/library/papers/41889778 | PubMed |
| 41826755 | Preferential remdesivir triphosphate incorporation by SARS-CoV-2 polymerase is altered to ATP by the S759A mutation. | Commun Biol | 2026 | https://conductscience.org/library/papers/41826755 | PubMed |
| 41754598 | Antiviral Activity of Remdesivir and Obeldesivir Against SARS-CoV-2 Omicron Subvariants That Were Circulating from September 2023 Through June 2025. | Viruses | 2026 | https://conductscience.org/library/papers/41754598 | PubMed |
| 41509513 | Inhibitory effects of molnupiravir on Crimean-Congo hemorrhagic fever virus polymerase. | NAR Mol Med | 2026 | https://conductscience.org/library/papers/41509513 | PubMed |
| 41427188 | Dynamical Fragment Molecular Orbital Interaction Analysis of SARS-CoV‑2 RNA-Dependent RNA Polymerase and Remdesivir. | ACS Omega | 2025 | https://conductscience.org/library/papers/41427188 | PubMed |
| 41282143 | Structural basis for selective remdesivir incorporation by SARS-CoV-2 polymerase, and S759A resistance. | Res Sq | 2025 | https://conductscience.org/library/papers/41282143 | PubMed |
| 41196062 | SARS-CoV-2 polyprotein expression and the induction of double-membrane vesicles. | J Virol | 2025 | https://conductscience.org/library/papers/41196062 | PubMed |
| 40913022 | Development of GFP-expressing infectious clones for PRRSV using TAR cloning for antiviral drug screening. | Npj Viruses | 2025 | https://conductscience.org/library/papers/40913022 | PubMed |
| 40900943 | Mechanism and spectrum of inhibition of viral polymerases by 2'-deoxy-2'-β-fluoro-4'-azidocytidine or azvudine. | NAR Mol Med | 2025 | https://conductscience.org/library/papers/40900943 | PubMed |
| 40872770 | SARS-CoV-2 Remdesivir Exposure Leads to Different Evolutionary Pathways That Converge in Moderate Levels of Drug Resistance. | Viruses | 2025 | https://conductscience.org/library/papers/40872770 | PubMed |
| 40806777 | Multi-Component Synthesis of New Fluorinated-Pyrrolo[3,4-b]pyridin-5-ones Containing the 4-Amino-7-chloroquinoline Moiety and In Vitro-In Silico Studies Against Human SARS-CoV-2. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40806777 | PubMed |
| 40699714 | A Multi-Model Machine Learning Framework for Identifying Raloxifene as a Novel RNA Polymerase Inhibitor from FDA-Approved Drugs. | Curr Issues Mol Biol | 2025 | https://conductscience.org/library/papers/40699714 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ACE2 | 59272 | PubTator's text mining | https://conductscience.org/library/genes/59272 | NCBI Gene |
| RTCA | 8634 | PubTator's text mining | https://conductscience.org/library/genes/8634 | NCBI Gene |
| SENP3 | 26168 | PubTator's text mining | https://conductscience.org/library/genes/26168 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36725929
GET https://conductscience.org/api/papers/v1/36725929/references?page=2